Location: Greenwich, CT
CIK: 0001596452 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 9, 2023
Total Value: $428M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF Trust | 400,000 | $177M | 41.5% | $443.28 | — | — | PUT | 78462F103 |
| XBI | SPDR S&P Biotech ETF | 250,000 | $20.8M | 4.9% | $83.20 | $83.06 | +0.2% | Cash Securities | 78464A870 |
| THC | Tenet Healthcare Corp | 140,000 | $11.39M | 2.7% | $81.38 | $47.24 | +72.3% | Cash Securities | 88033G407 |
| BSX | Boston Scientific Corp | 160,000 | $8.654M | 2.0% | $54.09 | $40.22 | +34.5% | Cash Securities | 101137107 |
| UHS | Universal Health Services Inc | 52,500 | $8.283M | 1.9% | $157.77 | $119.27 | +30.8% | Cash Securities | 913903100 |
| LLY | Eli Lilly & Co | 17,500 | $8.207M | 1.9% | $468.97 | $255.49 | +80.3% | Cash Securities | 532457108 |
| NVO | Novo Nordisk A/S | 50,000 | $8.092M | 1.9% | $161.84 | $112.99 | +43.2% | Cash Securities | 670100205 |
| CAH | Cardinal Health Inc | 85,000 | $8.038M | 1.9% | $94.56 * | $55.93 | +62.2% | Cash Securities | 14149Y108 |
| ZBH | Zimmer Biomet Holdings Inc | 55,000 | $8.008M | 1.9% | $145.60 * | $121.04 | +17.6% | Cash Securities | 98956P102 |
| BDX | Becton Dickinson & Co | 30,000 | $7.92M | 1.9% | $264.00 * | $237.10 | +6.4% | Cash Securities | 075887109 |
| SGRY | Surgery Partners Inc | 175,000 | $7.873M | 1.8% | $44.99 | $38.07 | +18.2% | Cash Securities | 86881A100 |
| HUM | Humana Inc | 17,500 | $7.825M | 1.8% | $447.14 * | $422.45 | +2.8% | Cash Securities | 444859102 |
| COR | AmerisourceBergen Corp | 40,000 | $7.697M | 1.8% | $192.43 * | $113.77 | +65.5% | Cash Securities | 03073E105 |
| ISRG | Intuitive Surgical Inc | 22,500 | $7.694M | 1.8% | $341.96 | $282.04 | +21.2% | Cash Securities | 46120E602 |
| SYK | Stryker Corp | 25,000 | $7.627M | 1.8% | $305.08 * | $214.01 | +39.2% | Cash Securities | 863667101 |
| HCA | HCA Healthcare Inc | 25,000 | $7.587M | 1.8% | $303.48 | $184.08 | +61.6% | Cash Securities | 40412C101 |
| MCK | McKesson Corp | 17,500 | $7.478M | 1.7% | $427.31 | $190.87 | +121.3% | Cash Securities | 58155Q103 |
| BAX | Baxter International Inc | 160,000 | $7.29M | 1.7% | $45.56 * | $60.56 | -29.2% | Cash Securities | 071813109 |
| EHC | Encompass Health Corp | 99,976 | $6.769M | 1.6% | $67.71 | $56.01 | +18.7% | Cash Securities | 29261A100 |
| ELV | Elevance Health Inc | 15,000 | $6.664M | 1.6% | $444.27 * | $420.51 | +1.6% | Cash Securities | 036752103 |
| ABT | Abbott Laboratories | 60,000 | $6.541M | 1.5% | $109.02 * | $94.42 | +10.0% | Cash Securities | 002824100 |
| IQV | IQVIA Holdings Inc | 27,500 | $6.181M | 1.4% | $224.76 | $195.83 | +14.8% | Cash Securities | 46266C105 |
| SEM | Select Medical Holdings Corp | 190,000 | $6.053M | 1.4% | $31.86 * | $15.21 | +8.1% | Cash Securities | 81619Q105 |
| DHR | Danaher Corp | 25,000 | $6M | 1.4% | $240.00 * | $143.32 | +46.6% | Cash Securities | 235851102 |
| MRK | Merck & Co Inc | 50,000 | $5.77M | 1.3% | $115.40 * | $98.68 | +8.2% | Cash Securities | 58933Y105 |
| CI | Cigna Group/The | 20,000 | $5.612M | 1.3% | $280.60 * | $229.20 | +16.9% | Cash Securities | 125523100 |
| MDT | Medtronic PLC | 60,000 | $5.286M | 1.2% | $88.10 * | $74.52 | +9.8% | Cash Securities | G5960L103 |
| ICLR | ICON PLC | 20,000 | $5.004M | 1.2% | $250.20 | $201.78 | +24.0% | Cash Securities | G4705A100 |
| VRTX | Vertex Pharmaceuticals Inc | 14,000 | $4.927M | 1.2% | $351.93 | $304.77 | +15.5% | Cash Securities | 92532F100 |
| UNH | UnitedHealth Group Inc | 10,000 | $4.806M | 1.1% | $480.60 * | $409.84 | +11.9% | Cash Securities | 91324P102 |
| ACHC | Acadia Healthcare Co Inc | 60,000 | $4.778M | 1.1% | $79.63 | $61.43 | +29.6% | Cash Securities | 00404A109 |
| BMRN | BioMarin Pharmaceutical Inc | 50,000 | $4.334M | 1.0% | $86.68 | $84.12 | +3.0% | Cash Securities | 09061G101 |
| TMO | Thermo Fisher Scientific Inc | 7,500 | $3.913M | 0.9% | $521.73 | $544.32 | -4.9% | Cash Securities | 883556102 |
| — | Catalent Inc | 70,000 | $3.035M | 0.7% | $43.36 | $43.36 | — | Cash Securities | 148806102 |
| BIIB | Biogen Inc | 10,000 | $2.849M | 0.7% | $284.90 | $212.38 | +34.1% | Cash Securities | 09062X103 |
| CRL | Charles River Laboratories In | 13,000 | $2.733M | 0.6% | $210.23 | $198.96 | +5.7% | Cash Securities | 159864107 |
| STVN | Stevanato Group SpA | 70,000 | $2.267M | 0.5% | $32.39 | $27.87 | +15.5% | Cash Securities | T9224W109 |
| AVTR | Avantor Inc | 75,000 | $1.541M | 0.4% | $20.55 | $20.22 | +1.6% | Cash Securities | 05352A100 |
| ALNY | Alnylam Pharmaceuticals Inc | 8,000 | $1.52M | 0.4% | $190.00 | $209.45 | -9.3% | Cash Securities | 02043Q107 |
| CYH | Community Health Systems Inc | 300,000 | $1.32M | 0.3% | $4.40 | $4.26 | +3.4% | Cash Securities | 203668108 |
| ARGX | Argenx SE | 3,000 | $1.169M | 0.3% | $389.67 | $393.32 | -0.9% | Cash Securities | 04016X101 |
| GRFS | Grifols SA | 62,843 | $576K | 0.1% | $9.17 | $8.25 | +11.0% | Cash Securities | 398438408 |
| SRPT | Sarepta Therapeutics Inc | 811 | $93,000 | 0.0% | $114.67 | $129.72 | -11.7% | Cash Securities | 803607100 |